This contract expires in 240 days (Feb 6, 2027).
FIRM FIXED PRICE
NOVARTIS PHARMACEUTICALS CORPORATION - LU177 - PLUVICTO/LUTATHERA
PIID: 36C25726N0205
Signed Date: Feb 6, 2026Effective Date: Feb 7, 2026End Date: Closes in 240 days
Award $
$4.2M
Vendor
NOVARTIS PHARMACEUTICALS CORPORATION
NAICS
325412
Signed Date
Feb 6, 2026
Key Details
Description
LU177 - PLUVICTO/LUTATHERA
Context & Analysis
On Feb 6, 2026, Department of Veterans Affairs obligated $4,162,659.22 to NOVARTIS PHARMACEUTICALS CORPORATION for lu177 - pluvicto/lutathera. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in EAST HANOVER, NJ. The contract is scheduled through Feb 6, 2027 — approximately 8 months remaining.
Contractor Information
Contractor: NOVARTIS PHARMACEUTICALS CORPORATION
UEI: NG61ZA8TADW3
CAGE Code: 04520
Location: EAST HANOVER, NJ
Stay Updated
Get notified about new opportunities matching your interests.